BANAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Banan, and what generic alternatives are available?
Banan is a drug marketed by Sankyo and is included in two NDAs.
The generic ingredient in BANAN is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Banan
A generic version of BANAN was approved as cefpodoxime proxetil by AUROBINDO PHARMA LTD on June 8th, 2007.
Summary for BANAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 2,093 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BANAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BANAN
US Patents and Regulatory Information for BANAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sankyo | BANAN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050688-002 | Aug 7, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sankyo | BANAN | cefpodoxime proxetil | TABLET;ORAL | 050687-002 | Aug 7, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sankyo | BANAN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050688-001 | Aug 7, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sankyo | BANAN | cefpodoxime proxetil | TABLET;ORAL | 050687-001 | Aug 7, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |